Siegfried Holding Gestione
Gestione criteri di controllo 2/4
Siegfried Holding Il CEO è Marcel Imwinkelried, nominato in Jan2024, ha un mandato di meno di un anno. possiede direttamente 0.008% delle azioni della società, per un valore di CHF 359.64K. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 5.6 anni e 4.6 anni.
Informazioni chiave
Marcel Imwinkelried
Amministratore delegato
n/a
Compenso totale
| Percentuale dello stipendio del CEO | n/a |
| Mandato del CEO | less than a year |
| Proprietà del CEO | 0.008% |
| Durata media del management | 5.6yrs |
| Durata media del Consiglio di amministrazione | 4.6yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Siegfried Holding AG's (VTX:SFZN) Price In Tune With Earnings
Nov 09
Is Siegfried Holding (VTX:SFZN) Using Too Much Debt?
Sep 12A Look At The Intrinsic Value Of Siegfried Holding AG (VTX:SFZN)
Aug 04Siegfried Holding AG (VTX:SFZN) Not Flying Under The Radar
Jun 17Siegfried Holding AG's (VTX:SFZN) CEO Compensation Looks Acceptable To Us And Here's Why
Apr 12Does Siegfried Holding (VTX:SFZN) Have A Healthy Balance Sheet?
Mar 15Earnings Miss: Siegfried Holding AG Missed EPS By 18% And Analysts Are Revising Their Forecasts
Feb 23Siegfried Holding AG's (VTX:SFZN) Business Is Yet to Catch Up With Its Share Price
Jan 27Is Siegfried Holding AG (VTX:SFZN) Worth CHF840 Based On Its Intrinsic Value?
Jan 07Is Now The Time To Put Siegfried Holding (VTX:SFZN) On Your Watchlist?
Dec 02We Think Siegfried Holding (VTX:SFZN) Can Stay On Top Of Its Debt
Nov 13A Look At The Intrinsic Value Of Siegfried Holding AG (VTX:SFZN)
Sep 28Here's Why We Think Siegfried Holding (VTX:SFZN) Might Deserve Your Attention Today
Aug 16With EPS Growth And More, Siegfried Holding (VTX:SFZN) Makes An Interesting Case
May 13Is Siegfried Holding (VTX:SFZN) Using Too Much Debt?
Apr 25With EPS Growth And More, Siegfried Holding (VTX:SFZN) Makes An Interesting Case
Jan 20Is Siegfried Holding (VTX:SFZN) A Risky Investment?
Dec 28Here's Why Siegfried Holding (VTX:SFZN) Has Caught The Eye Of Investors
Oct 13Siegfried Holding (VTX:SFZN) Has A Pretty Healthy Balance Sheet
Sep 25Should You Be Adding Siegfried Holding (VTX:SFZN) To Your Watchlist Today?
Jun 24Siegfried Holding (VTX:SFZN) Seems To Use Debt Quite Sensibly
Apr 08Do Siegfried Holding's (VTX:SFZN) Earnings Warrant Your Attention?
Mar 21Does Siegfried Holding (VTX:SFZN) Have A Healthy Balance Sheet?
Dec 23Should You Be Adding Siegfried Holding (VTX:SFZN) To Your Watchlist Today?
Dec 05Here's Why Siegfried Holding (VTX:SFZN) Can Manage Its Debt Responsibly
Sep 19If You Like EPS Growth Then Check Out Siegfried Holding (VTX:SFZN) Before It's Too Late
Sep 01These 4 Measures Indicate That Siegfried Holding (VTX:SFZN) Is Using Debt Reasonably Well
Jun 11Here's Why We Think Siegfried Holding (VTX:SFZN) Is Well Worth Watching
May 25Is Siegfried Holding (VTX:SFZN) A Risky Investment?
Mar 03Shareholders Are Thrilled That The Siegfried Holding (VTX:SFZN) Share Price Increased 227%
Jan 18Do Fundamentals Have Any Role To Play In Driving Siegfried Holding AG's (VTX:SFZN) Stock Up Recently?
Dec 22
What Kind Of Shareholders Hold The Majority In Siegfried Holding AG's (VTX:SFZN) Shares?
Nov 25AMMINISTRATORE DELEGATO
Marcel Imwinkelried (57 yo)
less than a year
Mandato
Mr. Marcel Imwinkelried serves as Chief Executive Officer at Siegfried Holding AG from 2024, was its Chief Operating Officer of Drug Products from October 1, 2021 until 2024 and served as its Chief Operati...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Chief Executive Officer | less than a year | Nessun dato | 0.0076% CHF 359.6k | |
| Chief Financial Officer | 7.5yrs | Nessun dato | 0.26% CHF 12.2m | |
| Chief Scientific Officer | 5.6yrs | Nessun dato | 0.049% CHF 2.3m | |
| General Counsel & Secretary | 5.8yrs | Nessun dato | Nessun dato | |
| Head of Corporate Communications | no data | Nessun dato | Nessun dato | |
| Chief Human Resources Officer | 1.3yrs | Nessun dato | 0.017% CHF 822.2k | |
| Chief Business Officer of Drug Substances & Drug Products | 3.8yrs | Nessun dato | 0.72% CHF 33.7m | |
| Head Global Quality Management DS - Zofingen | no data | Nessun dato | Nessun dato | |
| Chief Strategy Officer | 5.8yrs | Nessun dato | Nessun dato | |
| Head Regulatory Affairs - Site Zofingen | no data | Nessun dato | Nessun dato | |
| Head of Operations - Malta | no data | Nessun dato | Nessun dato | |
| Head Corporate Quality Systems - Global Quality Systems | no data | Nessun dato | Nessun dato |
5.6yrs
Durata media
56yo
Età media
Gestione esperta: Il team dirigenziale di SFZN è esperto e expertise (durata media dell'incarico 5.6 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Independent Non-Executive Chairman | 14.6yrs | CHF 484.81k | 0.48% CHF 22.4m | |
| Independent Non-Executive Director | 4.6yrs | CHF 227.31k | 0.022% CHF 1.0m | |
| Independent Non-Executive Director | 10.8yrs | CHF 220.91k | 0.081% CHF 3.8m | |
| Independent Non-Executive Vice Chairman | 8.8yrs | CHF 253.67k | 0.053% CHF 2.5m | |
| Independent Director | 2.6yrs | CHF 221.98k | 0.0085% CHF 400.1k | |
| Director | 1.6yrs | CHF 151.35k | 0.0046% CHF 215.8k | |
| Independent Director | 2.6yrs | CHF 216.70k | 0.0085% CHF 400.1k |
4.6yrs
Durata media
56yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di SFZN sono considerati esperti (durata media dell'incarico 4.6 anni).